Catechol-O-methyltransferase activity in rat brain primary neuronal and glial cell cultures and its inhibition by novel drugs

Neuroscience Research Communications

Volumn 25, Issue 2, 1999, Pages 71-77

  Reenilä, Ilkka ^a   Tuomainen, Päivi ^c   Soinila, Seppo ^a   Tuominen, Raimo K ^b   Männistö, Pekka T ^d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Div of Pharmacology and Toxicology   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Brain; Catechol O methyltransferase (COMT); Cell culture; CGP 28014; Entacapone; Tolcapone

Indexed keywords

CATECHOL METHYLTRANSFERASE; CATECHOL METHYLTRANSFERASE INHIBITOR; ENTACAPONE; N (6 OXO 1H PYRID 2 YL) N',N' DIPROPYLFORMAMIDINE; TOLCAPONE;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CATECHOLAMINE SYNTHESIS; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; GLIA CELL; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; NONHUMAN; RAT;

EID: 0032738186     PISSN: 08936609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6769(199909/10)25:2<71::AID-NRC2>3.0.CO;2-C     Document Type: Article

References (23)

1. Guldberg HC, Marsden CA. Catechol-O-methyl transferase: Pharmacological aspects and physiological role. Pharmacol Rev 1975;27:135-206
2. Kaplan GP, Hartman BK, Creveling CR. Immunohistochemical demonstration of catechol-O-methyltransferase in mammalian brain. Brain Res 1979;167:241-250
3. Karhunen T, Tilgmann C, Ulmanen I, Julkunen I, Panula P. Distribution of catechol-O-methyltransferase enzyme in rat tissues. J Histochem Cytochem 1994;42:1079-1090
4. Karhunen T, Tilgmann C, Ulmanen I, Panula P. Neuronal and non-neuronal catechol-O-methyltransferase in primary cultures of rat brain cells. Int J Devel Neurosci 1995;13:825-834
5. Reenilä IT, Tuomainen P, Soinila S, Männistö PT. Increase of catechol-O-methyltransferase activity in rat brain microglia after intrastriatal infusion of fluorocitrate, a glial toxin. Neurosci Lett 1997;230:155-158
6. Kaakkola S, Männistö PT, Nissinen E. Striatal membrane-bound and soluble catechol-O-methyltransferase after selective neuronal lesions in the rat. J Neural Transm-Gen Sect 1987;69:221-228
7. Rivett AJ, Francis A, Roth JA. Distinct cellular localization of membrane-bound and soluble forms of catechol-O-methyltransferase in brain. J Neurochem 1983;40:215-219
8. Ulmanen I, Peränen J, Tenhunen J, Tilgmann C, Karhunen T, Panula P. Expression and intracellular localization of catechol-O-methyltransferase in transfected mammalian cells. Eur J Biochem 1997;243:452-459
9. Wiese C, Cogoli-Greuter M, Weinreich R, Winterhalter KH. COMT inhibitors and metabolism of fluorodopa enantiomers in aggregating cell cultures. N-S Arch Pharmacol 1993;348:582-585
10. Hansson E. Enzyme activities of monoamine oxidase, catechol-O-methyltransferase and τ-aminobutyric acid transaminase in primary astroglial cultures and adult rat brain from different brain regions. Neurochem Res 1984;9:45-57
11. Männistö PT, Tuomainen P, Tuominen RK. Different in vivo properties of three new inhibitors of catechol-O-methyltransferase in the rat. Br J Pharmacol 1992;105:569-574
12. Waldmeier PC, Baumann PA, Feldtrauer J-J, Hauser K, Bittiger H, Bischoff S, Von Sprecher G. CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure. N-S Arch Pharmacol 1990;342:305-311
13. McMillian M, Vainio PJ, Tuominen RK. Role of protein kinase C in microglia-induced neurotoxicity in mesencephalic cultures. J Neuropathol Exp Neurol 1997;56:301-307
14. Reenilä I, Tuomainen P, Männistö PT. Improved assay of catechol-O-methyltransferase (COMT) activity by high-performance liquid chromatography with coulometric detection. J Chromatogr - Biomed Appl 1994;663:137-142
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254
16. Paetau A, Elovaara I, Paasivuo R, Virtanen I, Palo J, Haltia M. Glial filaments are a major brain fraction in infantile neuronal ceroid-lipofuscinosis. Acta Neuropathol 1985;65:190-194
17. Borges N, Vieira-Coelho MA, Parada A, Soares-da-Silva. Studies on the tight-binding nature of tolcapone inhibition of soluble and membrane-bound rat brain catechol-O-methyltransferase. J Pharmacol Exp Ther 1997;282:812-817
18. Vidgren J, Ovaska M. Structural aspects in the inhibitor design of catechol O-methyltransferase. In: Veerapandian P, editor. Structure-based drug design. New York:New York; 1997. p 343-363
19. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995;34:4202-4210
20. Nissinen E, Linden I-B, Schulte E, Pohto P. Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone. N-S Arch Pharmacol 1992;346:262-266
21. Zürcher G, Keller HH, Kettler R, Borgulya J, Bonetti EP, Eigenmann R, Da Prada M. Ro 40-7592, a novel, very potent, and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats. Adv Neurol 1990;53:497-503
22. Männistö PT, Ulmanen I, Lundström K, Taskinen J, Tenhunen J, Tilgmann C, Kaakkola S. Characteristics of catechol O-methyltransferase (COMT) and properties of selective COMT inhibitors. Prog Drug Res 1992;39:291-350
23. Zürcher G, Colzi A, Da Prada M. Ro 40-7592: inhibition of COMT in rat brain and extracerebral tissue. J Neural Transm 1990;Suppl 32:375-380